Additionally, INNO-406 treatment prevented MPP+-induced cellular toxicity in SHSY-5Y neuroblastoma cells suggesting that our in vivo observation of INNO-406 prevention of parkin phosphorylation and AIMP2 accumulation might play a major role in cell survival (Figure 4C). The gene discussed is PRKN; the disease is neuroblastoma.